Latest filing published 20 Nov 2018 for NRX Pharmaceuticals, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +5.4%Entry US$96.00 · Close at T+365 US$101.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Ackerman: trading record in brief
This profile gathers the share dealings of Richard Ackerman in NRX Pharmaceuticals, Inc. Over a trading history stretching from 29 November 2017 to 20 November 2018, the count stands at 2 filings.
Both buying and selling appear: 1 purchase worth €190k, against 1 sale. No amount is published for 1 filing, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2018: no purchases and 1 sale on the market.
The latest filing, published on 20 November 2018, reports an open-market sale in NRX Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 3,262 days ago, on 4 December 2017. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Richard Ackerman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,500,000 sharesCommon StockSEC:0001654954-18-013065:0
- 22,500 shares@ US$10.00100.0% of flowCommon StockSEC:0001654954-17-011320:0Canonical exit: 27 Feb 2018 (T+90)
2 of 2 declarations